Excision Repair Cross-complementation Group 1 is a Prognostic Biomarker in Patients with Colorectal Cancer Receiving Chemotherapy

BACKGROUND: Conflicting results about the association between expression level of excision repair cross-complementation group 1 (ERCC1) and clinical outcome in patients with colorectal cancer (CRC) receiving chemotherapy have been reported. Thus, we searched the available articles and performed the...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Mu-Xing, Bi, Xin-Yu, Zhao, Hong, Huang, Zhen, Han, Yue, Zhao, Dong-Bin, Zhao, Jian-Jun, Cai, Jian-Qiang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Medknow Publications & Media Pvt Ltd 2016
Materias:
Meta Analysis
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4804441/
https://www.ncbi.nlm.nih.gov/pubmed/26904994
http://dx.doi.org/10.4103/0366-6999.176993

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4804441/
https://www.ncbi.nlm.nih.gov/pubmed/26904994
http://dx.doi.org/10.4103/0366-6999.176993

Ejemplares similares